Astrocyte loss and astrogliosis in neuroinflammatory disorders

Neuroscience Letters

Volumn 565, Issue , 2014, Pages 39-41

  Hostenbach, Stephanie ^a   Cambron, Melissa ^a   D'haeseleer, Miguel ^a   Kooijman, Ron ^b   De Keyser, Jacques ^a,c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Astrocyte loss; Astrocytes; Astrogliosis; Multiple sclerosis; Neuroinflammation

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; BETA 2 ADRENERGIC RECEPTOR; CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 1; INTERLEUKIN 6; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ASTROCYTE; ASTROCYTOSIS; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; MAJOR DEPRESSION; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RASMUSSEN SYNDROME; REVIEW; SCAR FORMATION; UPREGULATION;

ASTROCYTE LOSS; ASTROCYTES; ASTROGLIOSIS; MULTIPLE SCLEROSIS; NEUROINFLAMMATION;

ANIMALS; ASTROCYTES; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; ENCEPHALITIS; GLIOSIS; HUMANS; INFLAMMATION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; NEUROMYELITIS OPTICA;

EID: 84897098224     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.10.012     Document Type: Review

References (33)

1. Baeuerle P.A., Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988, 242:540-546.
2. Balasingam V., Tejada-Berges T., Wright E., Bouckova R., Yong V.W. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 1994, 14:846-856.
3. Balasingam V., Yong V.W. Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 1996, 16:2945-2955.
4. Bauer J., Elger C.E., Hans V.H., Schramm J., Urbach H., Lassmann H., Bien C.G. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann. Neurol. 2007, 62:67-80.
5. Bien C.G., Granata T., Antozzi C., Cross J.H., Dulac O., Kurthen M., Lassmann H., Mantegazza R., Villemure J.G., Spreafico R., Elger C.E. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005, 128:454-471.
6. Bramlett H.M., Dietrich W.D. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab. 2004, 24:133-150.
7. Chesik D., Glazenburg L., De Keyser J., Wilczak N. Enhanced proliferation of astrocytes from beta(2)-adrenergic receptor knockout mice is influenced by the IGF system. J. Neurochem. 2007, 100:1555-1564.
8. D'Haeseleer M., Beelen R., Fierens Y., Cambron M., Vanbinst A.M., Verborgh C., Demey J., De Keyser J. Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc. Natl. Acad. Sci. USA 2013, 110:5654-5658.
9. De Keyser J., Wilczak N., Leta R., Streetland C. Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 1999, 53:1628-1633.
10. Dinapoli V.A., Benkovic S.A., Li X., Kelly K.A., Miller D.B., Rosen C.L., Huber J.D., O'Callaghan J.P. Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat. Neuroscience 2010, 170:633-644.
11. Gadea A., Schinelli S., Gallo V. Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J. Neurosci. 2008, 28:2394-2408.
12. Gavrilyuk V., Dello Russo C., Heneka M.T., Pelligrino D., Weinberg G., Feinstein D.L. Norepinephrine increases I kappa B alpha expression in astrocytes. J. Biol. Chem. 2002, 277:29662-29668.
13. Gavrilyuk V., Horvath P., Weinberg G., Feinstein D.L. A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells. J. Neurochem. 2001, 78:129-140.
14. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 1988, 8:2485-2490.
15. Jensen C.J., Massie A., De Keyser J. Immune players in the CNS: the astrocyte. J. Neuroimmune Pharmacol. 2013, 8:824-839.
16. Kim S.G., Soltysiak K.A., Gao Z.G., Chang T.S., Chung E., Jacobson K.A. Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors. Biochem. Pharmacol. 2003, 65:923-931.
17. Liu Y., Ho R.C., Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect Disord. 2012, 139:230-239.
18. Manosso L.M., Neis V.B., Moretti M., Daufenbach J.F., Freitas A.E., Colla A.R., Rodrigues A.L. Antidepressant-like effect of alpha-tocopherol in a mouse model of depressive-like behavior induced by TNF-alpha. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 46C:48-57.
19. Manwani B., Liu F., Scranton V., Hammond M.D., Sansing L.H., McCullough L.D. Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp. Neurol. 2013, 249C:120-131.
20. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation 2013, 10:43.
21. Okada S., Nakamura M., Mikami Y., Shimazaki T., Mihara M., Ohsugi Y., Iwamoto Y., Yoshizaki K., Kishimoto T., Toyama Y., Okano H. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J. Neurosci. Res. 2004, 76:265-276.
22. Pan W., Kastin A.J. Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog. Neurobiol. 2007, 83:363-374.
23. Popa-Wagner A., Carmichael S.T., Kokaia Z., Kessler C., Walker L.C. The response of the aged brain to stroke: too much, too soon?. Curr. Neurovasc. Res. 2007, 4:216-227.
24. Popa-Wagner A., Dinca I., Yalikun S., Walker L., Kroemer H., Kessler C. Accelerated delimitation of the infarct zone by capillary-derived nestin-positive cells in aged rats. Curr. Neurovasc. Res. 2006, 3:3-13.
25. Silveira G., de Oliveira A.C., Teixeira A.L. Insights into inflammation and epilepsy from the basic and clinical sciences. J. Clin. Neurosci. 2012, 19:1071-1075.
26. van Strien M.E., Breve J.J., Fratantoni S., Schreurs M.W., Bol J.G., Jongenelen C.A., Drukarch B., van Dam A.M. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?. PLoS One 2011, 6:e25037.
27. van Strien M.E., Drukarch B., Bol J.G., van der Valk P., van Horssen J., Gerritsen W.H., Breve J.J., van Dam A.M. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?. Brain Pathol. 2011, 21:44-54.
28. Wingerchuk D.M. Neuromyelitis optica spectrum disorders. Continuum (Minneap. Minn.) 2010, 16:105-121.
29. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6:805-815.
30. Woiciechowsky C., Schoning B., Stoltenburg-Didinger G., Stockhammer F., Volk H.D. Brain-IL-1 beta triggers astrogliosis through induction of IL-6: inhibition by propranolol and IL-10. Med. Sci. Monit. 2004, 10:BR325-BR330.
31. Wraith D.C., Nicholson L.B. The adaptive immune system in diseases of the central nervous system. J. Clin. Invest. 2012, 122:1172-1179.
32. Zeinstra E., Wilczak N., De Keyser J. [3H]dihydroalprenolol binding to beta adrenergic receptors in multiple sclerosis brain. Neurosci. Lett. 2000, 289:75-77.
33. Zhang D., Hu X., Qian L., O'Callaghan J.P., Hong J.S. Astrogliosis in CNS pathologies: is there a role for microglia?. Mol. Neurobiol. 2010, 41:232-241.